Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Sikkema, Tineke ^a   Schuiling, Wouter Jan ^a   Hoogendoorn, Mels ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GADOLINIUM; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISOLONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PREDNISONE; R-CHOP PROTOCOL;

ABDUCENS NERVE PARALYSIS; AGED; ARTICLE; ASTROCYTOSIS; ATAXIA; BALANCE DISORDER; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; DEATH; DEMYELINATION; DETERIORATION; DRUG MEGADOSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FRONTAL CORTEX; HEMIPARESIS; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JC VIRUS; LARGE CELL LYMPHOMA; LYMPHOCYTE; MACROPHAGE; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SIDE EFFECT; WEIGHT REDUCTION; WHITE MATTER; BIOPSY; BRAIN; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, LARGE B-CELL, DIFFUSE; PATHOLOGY;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BRAIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDNISONE; VINCRISTINE;

EID: 84874482278     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-008142     Document Type: Article

References (11)

1. Pelosini M, Focosi D, Rita F, et al. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol 2008;87:405-12.
2. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010;9:425-37.
3. Freim Wahl SG, Folvik MR, Torp SH. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol 2007;26:68-73. (Pubitemid 46408582)
4. Paues J, Vrethem M. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab. J Clin Virol 2010;48:291-3.
5. Carson KR, Focosi D, Major EO, et al. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the research on adverse drug events and reports (RADAR) Project. Lancet Oncol 2009;10:816-24.
6. Berger Jr. Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf 2010;33:969-83.
7. Keene DL, Legare C, Taylor E, et al. Monoclonal antibodies and progressive multifocal leukoencephalopathy. Can J Neurol Sci 2011;38:565-71.
8. Engsig FN, Hansen AB, Omland LH, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 2009;199:77-83.
9. Drews K, Bashir T, Dorries K. Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR. J Virol Methods 2000;84:23-36.
10. Tuccori M, Focosi D, Maggi F, et al. Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab. Ann Hematol 2010;89:519-22.
11. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the research on adverse drug events and reports project. Blood 2009;113:4834-40.